Genomma Lab - Business Information
Drug Stores & Pharmacies · Mexico · 2,365 Employees
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally. It provides skin care, health and wellness, haircare, pain relief, cough and cold, gastro, sexual health, antiperspirant deodorant, hand sanitizer, isotonic deink, and razor products, as well as analgesics, antifungals, and hemorrhoids. The company offers its products under the Cicatricure, Asepxia, Teatrical, Goicoechea, Sistema GB, Medicasp, Tío Nacho, Vanart, Novamil, Ultra Bengue, X-Ray, Tafirol, Alliviax, Bufferin, Next, XL-3, Genoprazol, QG5, Kaopectate, Proctan, Nikzon, Unesia, Silka Medic, lagicam, Suerox, Groomen, DiabetTX, and other brands. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.Read More
View Company Info for Free
Who is Genomma Lab
Headquarters
Phone Number
Website
Revenue
Stock Symbol
Industry
Genomma Lab Org Chart
Genomma Lab Tech Stack
Genomma Lab News & Media
GENOMMA LAB INTERNACIONAL INFORMS THE VOLUNTARILY PREPAYMENT OF THE SECOND TRANCHE OF ITS IFC SECURED LOAN
MEXICO CITY, Aug. 8, 2023 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, announced that on August 04, 2023 it...GENOMMA LAB MANUFACTURING FACILITY GRANTED COFEPRIS OPERATING LICENSE FOR ALL ITS PHARMA / OTC MANUFACTURING LINES
MEXICO CITY, Aug. 7, 2023 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, today announced that the Mexican...Genomma Lab Internacional Reports Second Quarter 2023 Results
MEXICO CITY, July 26, 2023 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma Lab" or "the Company"), today announced its results for the second quarter ended June 30, 2023. All figures included herein are stated in nominal Mexican pesos and have been...Genomma Lab Announces Second Quarter 2023 Financial Results Call and Webcast
MEXICO CITY, July 5, 2023 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), today announced that it will report its Second Quarter 2023 results on Wednesday, July 26, 2023 after the Mexican Market (BMV) close. The company also...
Frequently Asked Questions regarding Genomma Lab
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally. It provides skin care, health and wellness, hair care, pain relief, cough and cold, gastro, sexual health, antiperspirant deodorant, h... Read More